BRITTANY STUART: Open Payments
NPI 1184366098 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,835 in 111 payments from 24 companies in 2025. Trend: 2023 $2,056 · 2024 $4,003 · 2025 $2,835
Food & beverage: $2,712Travel & lodging: $101Speaker / faculty: $22
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 10 | $413 |
| Abbott Laboratories | 5 | $281 |
| Alnylam Pharmaceuticals Inc. | 11 | $212 |
| ABBVIE INC. | 5 | $191 |
| Biogen, Inc. | 9 | $190 |
| SK Life Science, Inc. | 10 | $185 |
| Teva Pharmaceuticals USA, Inc. | 8 | $152 |
| MDD US Operations, LLC | 14 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $135 |
| Amgen Inc. | 2 | $131 |
Products named: ULTOMIRIS, INFINITY, AMVUTTRA, AUSTEDO XR, QULIPTA, LEQEMBI, VUMERITY, REXULTI.
Industry payments across NY — which companies pay providers there.
